Gina Carithers
Showing 1–2 of 2 transcripts.
- Milken Institute1h 0m
Accelerating a Healthier Future Through AI | Global Conference 2025
Gina Carithers, Jesse Ehrenfeld, Tom Hale, Kate Sasser, Johnese Spisso
A panel of experts from the AMA, UCLA Health, Tempus AI, and Aura discusses how artificial intelligence is accelerating the adoption of tools like ambient scribes and genomic analysis to address critical primary care shortages and administrative burdens. These leaders detail successful implementations at scale, noting that while automated workflows and continuous patient monitoring are improving clinical accuracy and reducing provider burnout, significant hurdles remain regarding interoperability and fragmented prior authorization systems. Looking forward, the group envisions a regulatory landscape that scales with risk, enabling AI to support personalized, data-driven care models that include digital twins and citizen science while maintaining strict safety protocols for high-stakes medical decisions.
- Milken Institute1h 1m
The Next Wave of Immunotherapy and Cancer Treatments | Milken Institute Global Conference 2024
Marc Hurlbert, Gina Carithers, Friedrich Graf Finckenstein, Anusha Kalbasi, Connie Pfeiffer, Sunil Verma, Frederick Finckenstein, Neil Verma, Anusha Singhal
Major research organizations like the Melanoma Research Alliance and the Prostate Cancer Foundation have funded over $1 billion in studies that pioneered immune checkpoint inhibitors and novel T-cell therapies for melanoma and prostate cancer. Recent advancements include the approval of Iovance's tumor-infiltrating lymphocyte treatment for solid tumors and the development of bispecific agents that reduce manufacturing delays, though challenges regarding high costs, autoimmune side effects, and the need for broader genetic screening persist. Clinical strategies are shifting toward neoadjuvant trials and combination therapies with antibody-drug conjugates to improve patient outcomes before standard care options are exhausted.